Fennec Pharmaceuticals (FENC) Total Debt (2021 - 2022)
Fennec Pharmaceuticals (FENC) posted Total Debt of $25.0 million for Q4 2022, little changed on a QoQ basis from $25.0 million in Q3 2022, and up 265.87% year-over-year from $6.8 million in Q4 2021.
Fennec Pharmaceuticals (FENC) Total Debt (2021 - 2022) Analysis & Trends
Fennec Pharmaceuticals' Total Debt history runs 2 years deep, the most recent figure standing at $25.0 million for Q4 2022.
- Quarterly Total Debt rose 265.87% year-over-year to $25.0 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $25.0 million (up 265.87% YoY) and the FY2022 annual result came in at $25.0 million, up 265.87% from the prior year.
- Total Debt was $25.0 million for Q4 2022 at Fennec Pharmaceuticals, roughly flat from $25.0 million in the prior quarter.
- Across five years, Total Debt topped out at $25.0 million in Q3 2022 and bottomed at $1.8 million in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 25.00 Mn |
| Sep 30, 2022 | 25.00 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 6.83 Mn |
| Sep 30, 2021 | 1.83 Mn |
| Jun 30, 2021 | 2.00 Mn |